Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 19 | 2026 | 888 | 3.530 |
Why?
|
| Indians, North American | 15 | 2024 | 548 | 2.590 |
Why?
|
| Congenital Abnormalities | 4 | 2025 | 19 | 2.180 |
Why?
|
| Heart Defects, Congenital | 5 | 2026 | 96 | 2.020 |
Why?
|
| Oklahoma | 29 | 2026 | 1063 | 1.630 |
Why?
|
| Cancer Survivors | 2 | 2025 | 72 | 1.280 |
Why?
|
| Papillomavirus Infections | 5 | 2023 | 159 | 1.250 |
Why?
|
| Infertility | 3 | 2019 | 35 | 1.240 |
Why?
|
| Child | 21 | 2026 | 2354 | 1.210 |
Why?
|
| Infant | 17 | 2026 | 1067 | 1.200 |
Why?
|
| Healthcare Disparities | 3 | 2019 | 99 | 1.160 |
Why?
|
| Reproductive Techniques, Assisted | 2 | 2019 | 17 | 1.140 |
Why?
|
| Environmental Exposure | 3 | 2021 | 53 | 1.080 |
Why?
|
| Benzene | 2 | 2018 | 12 | 1.070 |
Why?
|
| Child, Preschool | 16 | 2026 | 1215 | 1.030 |
Why?
|
| Air Pollution | 2 | 2018 | 18 | 1.020 |
Why?
|
| Humans | 57 | 2026 | 29216 | 1.010 |
Why?
|
| Female | 43 | 2026 | 15827 | 1.000 |
Why?
|
| Registries | 17 | 2025 | 399 | 0.990 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2025 | 47 | 0.930 |
Why?
|
| Health Services Accessibility | 3 | 2026 | 123 | 0.890 |
Why?
|
| Adolescent | 19 | 2026 | 3255 | 0.850 |
Why?
|
| Infant, Newborn | 13 | 2026 | 932 | 0.790 |
Why?
|
| Male | 33 | 2026 | 14128 | 0.790 |
Why?
|
| Population Surveillance | 4 | 2019 | 87 | 0.760 |
Why?
|
| Vaccines | 1 | 2023 | 38 | 0.750 |
Why?
|
| Adult | 25 | 2026 | 8130 | 0.730 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2025 | 44 | 0.710 |
Why?
|
| United States | 18 | 2026 | 2275 | 0.700 |
Why?
|
| Young Adult | 14 | 2025 | 2877 | 0.680 |
Why?
|
| Papillomavirus Vaccines | 4 | 2022 | 74 | 0.630 |
Why?
|
| Water Pollution | 1 | 2018 | 7 | 0.570 |
Why?
|
| Natural Gas | 1 | 2018 | 6 | 0.570 |
Why?
|
| Cleft Palate | 1 | 2018 | 15 | 0.550 |
Why?
|
| Neural Tube Defects | 1 | 2018 | 20 | 0.550 |
Why?
|
| Incidence | 13 | 2026 | 581 | 0.540 |
Why?
|
| Paint | 1 | 2017 | 1 | 0.510 |
Why?
|
| Paternal Exposure | 1 | 2017 | 1 | 0.510 |
Why?
|
| Hepatoblastoma | 1 | 2017 | 6 | 0.510 |
Why?
|
| Environmental Pollutants | 1 | 2017 | 36 | 0.500 |
Why?
|
| Aged | 18 | 2026 | 5649 | 0.500 |
Why?
|
| Maternal Exposure | 1 | 2017 | 29 | 0.500 |
Why?
|
| Occupational Exposure | 1 | 2017 | 29 | 0.490 |
Why?
|
| Middle Aged | 20 | 2026 | 7496 | 0.490 |
Why?
|
| Vehicle Emissions | 1 | 2016 | 6 | 0.480 |
Why?
|
| Nitrogen Dioxide | 1 | 2016 | 6 | 0.480 |
Why?
|
| Leukemia | 1 | 2016 | 30 | 0.470 |
Why?
|
| Air Pollutants | 1 | 2016 | 19 | 0.470 |
Why?
|
| Breast Neoplasms | 4 | 2026 | 486 | 0.460 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 168 | 0.440 |
Why?
|
| Influenza, Human | 2 | 2026 | 101 | 0.430 |
Why?
|
| African Americans | 4 | 2020 | 353 | 0.420 |
Why?
|
| Case-Control Studies | 5 | 2022 | 741 | 0.400 |
Why?
|
| Qualitative Research | 2 | 2024 | 209 | 0.380 |
Why?
|
| Rural Population | 4 | 2026 | 140 | 0.380 |
Why?
|
| Logistic Models | 4 | 2017 | 415 | 0.370 |
Why?
|
| Risk Factors | 6 | 2026 | 2144 | 0.360 |
Why?
|
| Retrospective Studies | 7 | 2026 | 2664 | 0.350 |
Why?
|
| Body Weight | 1 | 2012 | 253 | 0.330 |
Why?
|
| Diabetes, Gestational | 2 | 2022 | 73 | 0.320 |
Why?
|
| Health Care Surveys | 3 | 2019 | 69 | 0.310 |
Why?
|
| Urban Population | 3 | 2026 | 97 | 0.310 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 556 | 0.310 |
Why?
|
| Survival Analysis | 4 | 2025 | 288 | 0.310 |
Why?
|
| Geographic Mapping | 2 | 2020 | 7 | 0.300 |
Why?
|
| Pregnancy | 5 | 2022 | 1260 | 0.300 |
Why?
|
| Proportional Hazards Models | 2 | 2023 | 226 | 0.300 |
Why?
|
| Geographic Information Systems | 2 | 2020 | 20 | 0.290 |
Why?
|
| Mortality | 2 | 2019 | 46 | 0.290 |
Why?
|
| Residence Characteristics | 2 | 2020 | 106 | 0.280 |
Why?
|
| Early Detection of Cancer | 3 | 2019 | 140 | 0.270 |
Why?
|
| SEER Program | 5 | 2024 | 47 | 0.260 |
Why?
|
| Prevalence | 3 | 2019 | 526 | 0.260 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2020 | 306 | 0.240 |
Why?
|
| Coinfection | 1 | 2026 | 20 | 0.240 |
Why?
|
| Odds Ratio | 2 | 2017 | 237 | 0.240 |
Why?
|
| Mobile Health Units | 1 | 2026 | 6 | 0.240 |
Why?
|
| Dried Blood Spot Testing | 1 | 2025 | 4 | 0.240 |
Why?
|
| Limb Deformities, Congenital | 1 | 2025 | 4 | 0.230 |
Why?
|
| Anal Canal | 1 | 2025 | 20 | 0.230 |
Why?
|
| Neonatal Screening | 1 | 2025 | 16 | 0.230 |
Why?
|
| Obesity | 1 | 2012 | 705 | 0.230 |
Why?
|
| Down Syndrome | 1 | 2025 | 20 | 0.230 |
Why?
|
| Trachea | 1 | 2025 | 43 | 0.230 |
Why?
|
| Commerce | 1 | 2026 | 61 | 0.230 |
Why?
|
| Esophagus | 1 | 2025 | 72 | 0.220 |
Why?
|
| Spine | 1 | 2025 | 63 | 0.220 |
Why?
|
| Mammography | 1 | 2026 | 83 | 0.220 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 2070 | 0.210 |
Why?
|
| Alaska Natives | 1 | 2024 | 13 | 0.210 |
Why?
|
| Kidney | 1 | 2025 | 290 | 0.200 |
Why?
|
| Poverty | 1 | 2024 | 90 | 0.200 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 103 | 0.200 |
Why?
|
| Mass Screening | 1 | 2024 | 160 | 0.190 |
Why?
|
| Travel | 1 | 2023 | 12 | 0.190 |
Why?
|
| Pilot Projects | 1 | 2024 | 467 | 0.190 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 481 | 0.190 |
Why?
|
| Parabens | 1 | 2022 | 5 | 0.180 |
Why?
|
| Tobacco Products | 1 | 2026 | 209 | 0.180 |
Why?
|
| Interviews as Topic | 2 | 2024 | 164 | 0.170 |
Why?
|
| Vaccination Coverage | 1 | 2021 | 14 | 0.170 |
Why?
|
| Research | 1 | 2022 | 93 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 415 | 0.170 |
Why?
|
| Electronic Health Records | 1 | 2022 | 67 | 0.170 |
Why?
|
| Arsenicals | 1 | 2021 | 5 | 0.170 |
Why?
|
| Arsenic | 1 | 2021 | 21 | 0.170 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 121 | 0.160 |
Why?
|
| Health Behavior | 1 | 2022 | 159 | 0.160 |
Why?
|
| Metabolomics | 1 | 2021 | 89 | 0.160 |
Why?
|
| Age Distribution | 2 | 2017 | 75 | 0.160 |
Why?
|
| Vaccination | 4 | 2024 | 222 | 0.160 |
Why?
|
| Topography, Medical | 1 | 2020 | 2 | 0.160 |
Why?
|
| Cohort Studies | 2 | 2019 | 903 | 0.150 |
Why?
|
| Delayed Diagnosis | 2 | 2016 | 19 | 0.150 |
Why?
|
| Documentation | 1 | 2019 | 28 | 0.150 |
Why?
|
| Hotlines | 1 | 2019 | 29 | 0.150 |
Why?
|
| Medicaid | 2 | 2016 | 55 | 0.150 |
Why?
|
| Social Class | 1 | 2019 | 82 | 0.150 |
Why?
|
| Health Services | 1 | 2019 | 12 | 0.140 |
Why?
|
| Transposition of Great Vessels | 1 | 2018 | 9 | 0.140 |
Why?
|
| Spatial Analysis | 1 | 2018 | 8 | 0.140 |
Why?
|
| Population Density | 1 | 2018 | 22 | 0.140 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 1013 | 0.140 |
Why?
|
| Regression Analysis | 1 | 2018 | 212 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 143 | 0.130 |
Why?
|
| Pregnancy Rate | 1 | 2018 | 49 | 0.130 |
Why?
|
| Insemination, Artificial | 1 | 2018 | 27 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2022 | 1288 | 0.130 |
Why?
|
| Walk Test | 1 | 2017 | 20 | 0.130 |
Why?
|
| Gasoline | 1 | 2017 | 9 | 0.130 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 9 | 0.130 |
Why?
|
| Solvents | 1 | 2017 | 40 | 0.130 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 131 | 0.130 |
Why?
|
| Age Factors | 2 | 2016 | 740 | 0.120 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2016 | 6 | 0.120 |
Why?
|
| Exercise Tolerance | 1 | 2017 | 82 | 0.120 |
Why?
|
| Testicular Neoplasms | 1 | 2016 | 16 | 0.120 |
Why?
|
| Motor Vehicles | 1 | 2016 | 6 | 0.120 |
Why?
|
| Medically Uninsured | 1 | 2016 | 31 | 0.120 |
Why?
|
| Survivors | 1 | 2016 | 40 | 0.120 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 40 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 194 | 0.120 |
Why?
|
| Acute Disease | 1 | 2016 | 158 | 0.120 |
Why?
|
| Walking | 1 | 2017 | 136 | 0.120 |
Why?
|
| Standard of Care | 1 | 2015 | 12 | 0.110 |
Why?
|
| Mastectomy, Segmental | 1 | 2015 | 20 | 0.110 |
Why?
|
| Mouth Neoplasms | 1 | 2016 | 64 | 0.110 |
Why?
|
| Melanoma | 1 | 2016 | 140 | 0.110 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 144 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 147 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2015 | 97 | 0.110 |
Why?
|
| Smoking Cessation | 1 | 2019 | 431 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 1033 | 0.100 |
Why?
|
| Texas | 2 | 2026 | 140 | 0.090 |
Why?
|
| Sex Distribution | 3 | 2016 | 78 | 0.090 |
Why?
|
| Social Environment | 1 | 2012 | 59 | 0.090 |
Why?
|
| Overweight | 1 | 2012 | 115 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2026 | 264 | 0.080 |
Why?
|
| Time Factors | 3 | 2019 | 1619 | 0.080 |
Why?
|
| Prognosis | 2 | 2025 | 817 | 0.080 |
Why?
|
| Students | 1 | 2012 | 203 | 0.070 |
Why?
|
| North Carolina | 1 | 2026 | 18 | 0.060 |
Why?
|
| Massachusetts | 1 | 2026 | 19 | 0.060 |
Why?
|
| Laos | 1 | 2026 | 20 | 0.060 |
Why?
|
| Anthropology, Medical | 1 | 2026 | 4 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2018 | 271 | 0.060 |
Why?
|
| Schools | 1 | 2026 | 90 | 0.060 |
Why?
|
| Hospitalization | 1 | 2026 | 207 | 0.050 |
Why?
|
| Health Status Disparities | 2 | 2016 | 66 | 0.050 |
Why?
|
| Pandemics | 1 | 2026 | 210 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2026 | 632 | 0.050 |
Why?
|
| Trust | 1 | 2024 | 26 | 0.050 |
Why?
|
| Universities | 1 | 2024 | 128 | 0.050 |
Why?
|
| Causality | 1 | 2023 | 13 | 0.050 |
Why?
|
| Phenol | 1 | 2022 | 7 | 0.050 |
Why?
|
| Phenols | 1 | 2022 | 22 | 0.050 |
Why?
|
| Pregnant Women | 1 | 2022 | 22 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 103 | 0.040 |
Why?
|
| Tooth, Deciduous | 1 | 2021 | 6 | 0.040 |
Why?
|
| Cacodylic Acid | 1 | 2021 | 5 | 0.040 |
Why?
|
| Methylation | 1 | 2021 | 24 | 0.040 |
Why?
|
| Immunization | 1 | 2021 | 133 | 0.040 |
Why?
|
| Alaska | 1 | 2020 | 42 | 0.040 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 17 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 73 | 0.040 |
Why?
|
| Biomarkers | 1 | 2022 | 790 | 0.040 |
Why?
|
| Censuses | 1 | 2018 | 4 | 0.040 |
Why?
|
| Asian Americans | 1 | 2018 | 40 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 433 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 204 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 303 | 0.030 |
Why?
|
| Rectal Neoplasms | 1 | 2016 | 10 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2017 | 128 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 484 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 468 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 122 | 0.030 |
Why?
|
| Medicare | 1 | 2015 | 127 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 304 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 360 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 2442 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 10806 | 0.020 |
Why?
|